#South Korea #Seoul #Atrial Fibrillation #Sky Labs #CART Monitor

Innovative Blood Pressure Monitoring with the CART Device

At the recent ESC Congress 2026 in Munich, Sky Labs made headlines with its presentation of the innovative CART blood pressure monitor. This groundbreaking device, shaped like a ring, has shown effectiveness in continuously monitoring blood pressure for patients suffering from atrial fibrillation (AF) and heart failure (HF). The company’s CEO, Jack ByungHwan Lee, highlighted the potential of the CART monitor to transform cardiovascular care through advanced monitoring techniques.

Clinical Research Outcomes

A review of clinical efficacy was presented by notable medical professionals, including Professor Ki-Hong Lee from Chonnam National University Hospital, who discussed a 24-hour blood pressure monitoring study on patients with AF. He reported an impressive data evaluability rate of around 80%. "With CART, we achieved continuous monitoring that allows for precise observations of nighttime blood pressure patterns," said Lee.

Similarly, Professor In-Cheol Kim from Keimyung University Dongsan Hospital shared results from heart failure patients. His findings showed that when comparing CART with conventional ambulatory blood pressure monitoring, the results demonstrated high concordance, meeting the stringent error margin criteria outlined by the European Society of Hypertension (ESH).

Advantages of the CART Monitor

What sets the CART apart from traditional methods is its ability to function without a conventional cuff, which often poses challenges for accurate readings, especially in patients with irregular pulses. This is particularly significant for those with AF and HF, where technical limitations of traditional cuffs can impede effective management.

Other notable findings included the report by Professor Hae-Young Lee of Seoul National University Hospital, who confirmed that CART measurements fulfilled multiple ESH criteria for cuffless devices, asserting its precision during various tests, including the awake/asleep test and exercise evaluations.

Moreover, Professor Eun-Mi Lee from Dongguk University illustrated how CART benefitted a patient troubled by cuff-related discomfort and stress. This adjustment allowed for safer medication reductions, further showcasing the clinical versatility of this innovative monitor.

Addressing Sleep Apnea Concerns

Professor Jong-Chan Youn from Seoul St. Mary’s Hospital presented alarming results from a study on sleep apnea patients, indicating sharp increases in blood pressure post-resumption of breathing during 12,000 episodes monitored. These findings underline the need for comprehensive blood pressure management in sleep-disorder patients, emphasizing the capabilities of the CART device.

As quoted by Professor Seok-Min Kang from Severance Hospital and Professor George Stergiou from the National and Kapodistrian University of Athens, Sky Labs has positioned itself as one of the few companies worldwide that meet the strict validation standards for cuffless measurement devices.

Market Impact and Future Plans

The CART blood pressure monitor employs advanced PPG sensors and artificial intelligence-driven deep learning algorithms to achieve 24-hour blood pressure monitoring without a cuff. Currently, it is actively prescribed in over 2,000 medical institutions across Korea, with over 300,000 prescriptions issued to date. The device was also recently endorsed in the 2026 guidelines of the Korean Society of Hypertension, marking a significant milestone for cuffless blood pressure monitoring technology.

Looking ahead, Sky Labs is poised to expand its reach into European and global markets, fueled by the success and recognition garnered at the ESC Congress. This illustrates an ongoing commitment to enhancing cardiovascular disease management through innovative technology.

About Sky Labs

Founded in September 2015, Sky Labs is dedicated to developing cutting-edge health technology, particularly its CART device, aimed at chronic disease monitoring. In 2023, the company secured medical approval for its 24-hour blood pressure monitoring device, CART BP pro, which has since gained inclusion as a reimbursable option in existing ambulatory monitoring protocols. In 2025, they launched the consumer-focused CART BP, placing this advanced health technology into the hands of the general public.

In conclusion, the introduction of the CART blood pressure monitor signals a new era in managing conditions such as atrial fibrillation and heart failure. As Sky Labs continues to innovate, the benefits for patient management and therapeutic care will undoubtedly expand, providing much-needed support for healthcare providers in managing these complex cardiovascular issues effectively.